Therapeutic Solutions International's Subsidiary MolecuVax, Inc. to Initiate Cancer Immunotherapy Clinical Trial Aimed at Eradicating Cancer Stem Cells Using MVAX-001
11 avr. 2016 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - April 11, 2016) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the signing of an agreement between its subsidiary, MolecuVax, Inc.,...
Therapeutic Solutions International Announces the Appointment of
Dr. Hong Ma as Chief Scientific Officer
16 mars 2016 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - March 16, 2016) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) a public clinical stage company focused on immune modulation for the treatment of...
Therapeutic Solutions International Announces the Licensing of Exosome Technology to MolecuVax, Inc.
08 févr. 2016 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - February 08, 2016) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that the Company has licensed their Exosome Patent to MolecuVax,...
Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre
25 janv. 2016 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - January 25, 2016) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the signing of an exclusive intellectual property license agreement...
Therapeutic Solutions International Announces the Appointment of BioPharmaceutical Pioneer Thomas E. Ichim, Ph.D to Board of Directors
22 janv. 2016 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - January 22, 2016) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the appointment of Dr. Thomas E. Ichim to our Board of Directors. Dr....
Therapeutic Solutions International Announces the Appointment of Dr. Barry Glassman to the TSI Scientific Advisory Board
05 janv. 2016 09h00 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - January 05, 2016) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that Barry Glassman, DMD, DAAPM, DAACP, FICCMO, Diplomate ABDSM,...
Therapeutic Solutions International Announces the Licensing of Probiotic Technology to OmniBiome, Inc.
08 déc. 2015 08h55 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - Dec 8, 2015) - Therapeutic Solutions International, Inc. (OTC PINK: TSOI) announced today that the Company has licensed an additional Patent to OmniBiome, Inc....
Therapeutic Solutions International Files Patent on Anticancer Nanotechnology Based Immunotherapy
23 nov. 2015 08h55 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - Nov 23, 2015) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today a patent for developing a future generation of immune cell derived...
Therapeutic Solutions International Announces the Licensing of Patents to OmniBiome and the Appointment of Iryna Dzieciuch, M.S. as Chief Executive Officer of OmniBiome
18 nov. 2015 08h55 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - Nov 18, 2015) - Therapeutics Solutions International, Inc. (OTC PINK: TSOI) announced today that the Company has licensed three Patents to OmniBiome, Inc....
Therapeutic Solutions International Announces the Appointment of Michael G. Agadjanyan, Ph.D. to Company Scientific Advisory Board
19 oct. 2015 08h55 HE
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - Oct 19, 2015) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that Michael Agadjanyan, Ph.D. has been appointed to our Scientific...